This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Alimta

Eli Lilly & Company

Drug Names(s): pemetrexed, LY231514

Description: Alimta (Pemetrexed for injection) is an antifolate antineoplastic agent that exerts its action by disrupting folate-dependent metabolic processes essential for cell replication. It main mechanism of action is the inhibition of the folate-dependent enzyme thymidylate synthase (TS) resulting in inhibition of de novo thymidylate and DNA synthesis.


Alimta News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug